Published in
Oxford University Press (OUP), Neuro-Oncology, suppl_6(19), p. vi139-vi139
DOI: 10.1093/neuonc/nox168.569
Links
Tools
NCOG-08. NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS
Journal article published in 2017 by
Martin Klein,
Jaap C. Reijneveld,
Ahmed Idbaih,
Walter Taal 
,
Paul M. Clement,
Filip de Vos ,
Antje Wick,
Paul Mulholland,
Martin J. B. Taphoorn,
Joanne Lewis,
Michael Weller,
Tina Verschuere,
Vassilis Golfinopoulos,
Thierry Gorlia,
Martin van den Bent
,
Paul M. Clement,
Filip de Vos ,
Antje Wick,
Paul Mulholland,
Martin J. B. Taphoorn,
Joanne Lewis,
Michael Weller,
Tina Verschuere,
Vassilis Golfinopoulos,
Thierry Gorlia,
Martin van den Bent
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 